Tokyo
Japan
5
2021-12-16
4
2019-04-09
These are the the leading inventors for applications assigned to TELLA, INC:
TELLA, INC based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
USE OF GLUCOSYLCERAMIDE SYNTHASE GENE-DEFICIENT T CELL AND THERAPEUTIC UTILIZATION THEREOF
#2 | 2016-12-15 ✅ Patent 10,253,075 granted on 2019-04-09WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
#3 | 2016-07-07 ✅ Patent 10,172,925 granted on 2019-01-08Uses of partial peptides of survivin and variations thereof
#4 | 2014-05-01 ✅ Patent 9,404,083 granted on 2016-08-02Method for amplifying NK cells
#5 | 2008-01-24 ✅ Patent 9,205,111 granted on 2015-12-08Process for producing engineered targeted T cell and medicine
Also check out Tella, Inc.'s (Tokyo, Japan) applicant profile with 1 patent applications submitted.
63215 ⎘